Octreotide Acetate
NDC 67457-239 · Mylan Institutional LLC
Packages
67457-239-01 — 10 SYRINGE in 1 CARTON (67457-239-01) / 1 mL in 1 SYRINGE (67457-239-00)
Billed under HCPCS
J2354 — Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg Medicare Part B payment limit (ASP + 6%): $0.60
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
23155-686 — octreotide acetate, 23155-687 — octreotide acetate, 23155-688 — octreotide acetate, 23155-689 — octreotide acetate, 52958-046 — octreotide acetate, 62756-452 — octreotide acetate, 63323-376 — OCTREOTIDE ACETATE, 63323-377 — OCTREOTIDE ACETATE, 63323-378 — OCTREOTIDE ACETATE, 63323-379 — OCTREOTIDE ACETATE, 67457-245 — octreotide acetate, 67457-246 — octreotide acetate, 68083-515 — Octreotide Acetate, 68083-516 — Octreotide Acetate, 68083-517 — Octreotide Acetate, 68083-560 — Octreotide Acetate, 68462-896 — Octreotide Acetate, 68462-897 — Octreotide Acetate, 71288-566 — Octreotide Acetate, 71288-567 — Octreotide Acetate, +10 more
Poisoning, adverse-effect and underdosing codes for this drug
The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.
T38.991 — Poisoning by other hormone antagonists, accidental (unintentional), T38.992 — Poisoning by other hormone antagonists, intentional self-harm, T38.993 — Poisoning by other hormone antagonists, assault, T38.994 — Poisoning by other hormone antagonists, undetermined, T38.995 — Adverse effect of other hormone antagonists, T38.996 — Underdosing of other hormone antagonists